Skip to main content

Table 2 General characteristics of patients and controls included in our study.

From: Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study

Subject characteristics

Cases

(n = 305)

Controls

(n = 305)

P-value

Stable CAD (%)

37.4

-

 

ACS (%)

62.6

-

 

Age (years)

63.14 ± 11.41

60.37 ± 14.86

0.011

Male sex (%)

81.6

70.2

0.001

BMI (kg/m 2 )

27.9 ± 3.8

28.2 ± 4.6

0.403

Hypercholesterolemia (%)

76.9

59.0

<0.001

Diabetes (%)

32.4

15.1

<0.001

Hypertension (%)

71.7

58.8

0.001

Family history of MI (%)

28.0

16.7

0.001

Current or former smoking (%)

74.2

61.0

<0.001

Total cholesterol (mg/dl)

197.7 ± 47.7

214.4 ± 40.4

<0.001

LDL cholesterol (mg/dl)

126.6 ± 41.6

141.2 ± 36.4

<0.001

HDL cholesterol (mg/dl)

50.6 ± 12.6

45.8 ± 14.3

<0.001

Triglycerides (mg/dl)

144.2 ± 66.8

118.1 ± 65.6

<0.001